Literature DB >> 8136262

Immunotoxins for the treatment of leukaemia.

F M Uckun1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8136262     DOI： 10.1111/j.1365-2141.1993.tb03329.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

Review 2.  Immunotoxins for the treatment of B-cell lymphomas.

Authors:  M A Ghetie; V Ghetie; E S Vitetta
Journal:  Mol Med       Date:  1997-07       Impact factor: 6.354

3.  Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.

Authors:  Holly J Meany; Nita L Seibel; Mark Krailo; Doojduen Villaluna; Zhengjia Chen; Paul Gaynon; Joseph P Neglia; Julie R Park; Raymond Hutchinson; Judith K Sato; Robert J Wells; William G Woods; Gregory Reaman
Journal:  J Immunother       Date:  2015-09       Impact factor: 4.456

4.  Generation of pokeweed antiviral protein mutations in Saccharomyces cerevisiae: evidence that ribosome depurination is not sufficient for cytotoxicity.

Authors:  Katalin A Hudak; Bijal A Parikh; Rong Di; Marianne Baricevic; Maria Santana; Mirjana Seskar; Nilgun E Tumer
Journal:  Nucleic Acids Res       Date:  2004-08-10       Impact factor: 16.971

5.  Membrane-associated CD19-LYN complex is an endogenous p53-independent and Bc1-2-independent regulator of apoptosis in human B-lineage lymphoma cells.

Authors:  D E Myers; X Jun; K G Waddick; C Forsyth; L M Chelstrom; R L Gunther; N E Tumer; J Bolen; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

Review 6.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 7.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 8.  Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience.

Authors:  David J Flavell; Sopsamorn U Flavell
Journal:  Toxins (Basel)       Date:  2022-08-18       Impact factor: 5.075

9.  Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.

Authors:  D J Flavell; S U Flavell; D A Boehm; L Emery; A Noss; N R Ling; P R Richardson; D Hardie; D H Wright
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

10.  Immunotoxins: a review of their use in cancer treatment.

Authors:  G Aruna
Journal:  J Stem Cells Regen Med       Date:  2006-12-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.